Novartis’ Kisqali Could Challenge Pfizer’s Ibrance After Phase II First-Line Aggressive Breast Cancer Success

 
• By Ayisha Sharma
  
Image of blue woman with red circle in breast, representing breast cancer
Chemotherapy Remains The Treatment Of Choice When There Is Organ Damage • Source: Shutterstock

More from Clinical Trials

More from R&D